Biomedicine and Chemical Sciences
2024, Volume 3, Issue 4 : 147-158 doi: https://doi.org/10.5281/zenodo.15777196
Research Article
Detection of bla OXA-48 and bla IMP Resistance Genes in Escherichia coli and Klebsiellapneumoniae Isolated from Children with Urinary Tract Infections
 ,
 ,
Received
Jan. 23, 2024
Revised
Sept. 18, 2024
Accepted
Sept. 24, 2024
Published
Oct. 1, 2024
Abstract

The pathogens Escherichia coli and Klebsiella pneumoniae are often involved in urinary tract infections (UTIs), which are common, especially in children. Due to their association with antibiotic resistance, which makes treatment tactics more difficult, the presence of the bla OXA-48 and bla IMP genes in these bacteria is essential. To detect two resistant genes, bla OXA-48 and bla IMP, in Klebsiella pneumoniae and Escherichia coli and to detect the variant genes by sequencing for each bacterium. In all, one hundred urine samples from children with UTIs were investigated. Using molecular techniques and gene sequencing, the isolates were tested for antibiotic resistance, ESBL phenotypic detection, and bla OXA-48 and bla IMP gene identification. The SPSS software was used to do the statistical analysis. K. pneumoniae and E. coli, the two most common isolates, exhibit significant rates of resistance to commonly used antibiotics. Genesbla OXA-48 was present in 92.3% of E. coli isolates and 100% of K. pneumoniae isolates, and bla IMP was present in 43.1% of E. coli isolates and 25.7% of K. pneumoniae isolates. The amplified blaIMP-1 sequences of E. coli and K. pneumoniae did not show any nucleic acid variation in the samples under analysis. While the results of the alignment of the amplified bla OXA samples with K.pneumoniaeand E. coli revealed the existence of two nucleic acid variations referring to reference nucleic acid sequences of K. pneumoniae and E. coli, respectively. The study shows that K. pneumoniae and E. coli both have significant levels of the bla OXA-48 and bla IMP genes. To prevent the spread of bacteria that cause antibiotic-resistant UTIs in children’s populations, our results emphasise the need for increased surveillance and monitoring of antibiotic regimens.

Keywords
REFERENCES
  1. Agbor, V. O., Ma’Ori, L., & Opajobi, S. O. (2011). Bacterial resistance to cephalosporins in clinical isolates in Jos University Teaching Hospital (JUTH). New York Science, 22(4), 9-13.
  2. Bagnola, E. (2018). Urinary tract infections in a long-term care facility: a prevalence study (Bachelor's thesis, Kent State University).
  3. Ballén, V., Gabasa, Y., Ratia, C., Ortega, R., Tejero, M., & Soto, S. (2021). Antibiotic resistance and virulence profiles of Klebsiella pneumoniae strains isolated from different clinical sources. Frontiers in Cellular and Infection Microbiology, 11, 738223. https://doi.org/10.3389/fcimb.2021.738223
  4. Banerjee, S., Sengupta, M., & Sarker, T. K. (2017). Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian Journal of Urology, 33(2), 149-154. https://doi.org/10.4103/iju.IJU_285_16
  5. Chang, D., Sharma, L., Dela Cruz, C. S., & Zhang, D. (2021). Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Frontiers in microbiology, 12, 750662. https://doi.org/10.3389/fmicb.2021.750662
  6. Chen, Y. T., Lin, J. C., Fung, C. P., Lu, P. L., Chuang, Y. C., Wu, T. L., & Siu, L. K. (2014). KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. Journal of Antimicrobial Chemotherapy, 69(3), 628-631. https://doi.org/10.1093/jac/dkt409
  7. Gurung, S., Kafle, S., Dhungel, B., Adhikari, N., Thapa Shrestha, U., Adhikari, B., ... & Ghimire, P. (2020). Detection of OXA-48 gene in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from urine samples. Infection and drug resistance, 2311-2321. https://doi.org/10.2147/IDR.S259967
  8. Jalil, M. B., & Al Atbee, M. Y. N. (2022). The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 36(9), e24619. https://doi.org/10.1002/jcla.24619
  9. Jones, K. (2023). Considerations for extended spectrum beta-lactamase (esbl)-producers in nursing homes. MJH Life Sciences.
  10. Karki, R. (2023). Multidrug resistance and extended spectrum β-lactamase producing Escherichia coli and klebsiella pneumoniae isolates from urine samples of patients attending a Hospital of Sunsari, Nepal (Doctoral dissertation, Department of Microbiology Central Campus of Technology, Dharan, Nepal TU Registration Number: 5-2-0003-0451-2013 2023 Tribhuvan University).
  11. Li, W., Guo, H., Gao, Y., Yang, X., Li, R., Li, S., ... & Li, X. (2022). Comparative genomic analysis of plasmids harboring bla OXA-48-like genes in Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology, 12, 1082813. https://doi.org/10.3389/fcimb.2022.1082813
  12. Logan, L. K., & Weinstein, R. A. (2017). The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. The Journal of infectious diseases, 215(suppl_1), S28-S36. https://doi.org/10.1093/infdis/jiw282
  13. Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., & Biondo, C. (2023). Urinary tract infections: the current scenario and future prospects. Pathogens, 12(4), 623. https://doi.org/10.3390/pathogens12040623
  14. Minardi, D., d’Anzeo, G., Cantoro, D., Conti, A., & Muzzonigro, G. (2011). Urinary tract infections in women: etiology and treatment options. International journal of general medicine, 333-343. https://doi.org/10.2147/IJGM.S11767
  15. Mohammed, A. B., & Anwar, K. A. (2022). Phenotypic and genotypic detection of extended spectrum beta lactamase enzyme in Klebsiella pneumoniae. PloS one, 17(9), e0267221. https://doi.org/10.1371/journal.pone.0267221
  16. Najjuka, C. F., Kateete, D. P., Kajumbula, H. M., Joloba, M. L., & Essack, S. Y. (2016). Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda. BMC research notes, 9, 1-14. https://doi.org/10.1186/s13104-016-2049-8
  17. Pishtiwan, A. H., & Khadija, K. M. (2019). Prevalence of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolated from thalassemia patients in Erbil, Iraq. Mediterranean journal of hematology and infectious diseases, 11(1), e2019041. https://doi.org/10.4084/MJHID.2019.041
  18. Poirel, L., Potron, A., & Nordmann, P. (2012). OXA-48-like carbapenemases: the phantom menace. Journal of Antimicrobial Chemotherapy, 67(7), 1597-1606. https://doi.org/10.1093/jac/dks121
  19. Rahman, S., Ali, T., Ali, I., Khan, N. A., Han, B., & Gao, J. (2018). The growing genetic and functional diversity of extended spectrum beta‐lactamases. BioMed research international, 2018(1), 9519718. https://doi.org/10.1155/2018/9519718
  20. Rizwan, M., Akhtar, M., Najmi, A. K., & Singh, K. (2018). Escherichia coli and Klebsiella pneumoniae sensitivity/resistance pattern towards antimicrobial agents in primary and simple urinary tract infection patients visiting university hospital of Jamia Hamdard New Delhi. Drug research, 68(07), 415-420. https://doi.org/10.1055/a-0576-0079
  21. Singh, S., Pathak, A., Fatima, N., Sahu, C., & Prasad, K. N. (2023). Characterisation of OXA-48-like carbapenemases in Escherichia coli and Klebsiella pneumoniae from North India. 3 Biotech, 13(5), 134. https://doi.org/10.1007/s13205-023-03537-8
  22. Wang, F., Wang, L., Chen, H., Li, N., Wang, Y., Li, Y., & Liang, W. (2021). Rapid detection of bla KPC, bla NDM, bla OXA-48-like and bla IMP carbapenemases in enterobacterales using recombinase polymerase amplification combined with lateral flow strip. Frontiers in Cellular and Infection Microbiology, 11, 772966. https://doi.org/10.3389/fcimb.2021.772966
  23. Zhang, F., Li, Q., Bai, J., Ding, M., Yan, X., Wang, G., ... & Zhou, Y. (2021). Heteroresistance to amikacin in carbapenem-resistant Klebsiella pneumoniae strains. Frontiers in Microbiology, 12, 682239. https://doi.org/10.3389/fmicb.2021.682239
Recommended Articles
Original Article Open Access
A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING
2025, Volume 4, Issue 4 : 26-34
Research Article Open Access
Design and Synthesis Ligands Tetradents Substituted with Halogenes in α- Position and Conjugation with Riboflavin (Bioconjugates)
2022, Volume 1, Issue 2 : 47-56
DOI: https://doi.org/10.48112/bcs.v1i2.85
Research Article Open Access
The Role of Vitamin D and Zinc In Facing COVID-19 Injury
2022, Volume 1, Issue 1 : 6-10
DOI: https://doi.org/10.48112/bcs.v1i1.76
Research Article Open Access
Spectroscopic and Thermal Studies of Some Palladium(II) Complexes with 2-amino-4-(4-subsistuted phenyl)thiazole Derivatives
2022, Volume 1, Issue 2 : 78-82
DOI: https://doi.org/10.48112/bcs.v1i2.104
Biomedicine and Chemical Sciences journal thumbnail
Volume 3, Issue 4
Citations
2 Views
0 Downloads
Share this article
License
Copyright (c) Biomedicine and Chemical Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Biomedicine and Chemical Sciences Logo
Biomedicine and Chemical Sciences
About Us
Biomedicine and Chemical Sciences (BCS), an international journal, publishes double blind peer-reviewed full-length, original papers, reviews or letters. BCS covers the latest developments in various fields of biomedicine such as cardiology, immunology, genetics, environmental health, neurology, oncology and toxicology
Support
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright Biomedicine and Chemical Sciences (BCS). All Rights Reserved.